There was a study assessed the efficacy of Ad-ΔLMP1-LMP2 transduced DCs vaccine in total 12 patients with NPC, this vaccine increased the activity of LMP1/2-specific T cells in vitro (64). The gene discussed is PDLIM7; the disease is nasopharyngeal carcinoma.